TrialOncotarget2017

Feasibility of abbreviated cycles of immunochemotherapy for completely resected limited-stage CD20+ diffuse large B-cell lymphoma (CISL 12-09).

Dok Hyun Yoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.